Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunjing Bian

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Oncology Reports|December 17, 2008
Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatinYe Bu, Chunhua Lu, Chunjing Bian, et al.
Annals of Surgical Oncology|August 1, 2024
Clinical Effectiveness and Safety of Transarterial Chemoembolization: Hepatic Artery Infusion Chemotherapy Plus Tyrosine Kinase Inhibitors With or Without Programmed Cell Death Protein-1 Inhibitors for Unresectable Hepatocellular Carcinoma-A Retrospective StudyYue Chen, Luyao Jia, Yu Li, et al.
Cryobiology|November 22, 2022
Feasibility and safety of trans-biliary cryoablation: Preclinical evaluation of a novel flexible cryoprobeChao Zhang, Linzhong Zhu, Shousheng Tang, et al.
The British Journal of Radiology|May 5, 2026
Efficacy and safety of transarterial chemoembolization and radiofrequency ablation plus tyrosine kinase inhibitors with or without PD-1 inhibitors for unresectable hepatocellular carcinomaYue Chen, Luyao Jia, Yibo Sun, et al.
Asian Journal of Surgery|June 12, 2022
Identification of key microRNAs in exosomes derived from patients with the severe acute pancreatitisYuanxu Qu, Yixuan Ding, Jiongdi Lu, et al.
Stem Cells and Development|January 18, 2011
NANOG has a role in mesenchymal stem cells' immunomodulatory effectZhao Sun, Qin Han, Yashu Zhu, et al.
Nature Communications|February 12, 2019
NADP<sup>+</sup> is an endogenous PARP inhibitor in DNA damage response and tumor suppressionChunjing Bian, Chao Zhang, Tao Luo, et al.
Journal of Advanced Research|November 7, 2025
The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinomaWentong Mei, Yixuan Ding, Chunjing Bian, et al.
Scientific Reports|April 1, 2024
In vivo evaluation of safety and performance of a tapered nitinol venous stent with inclined proximal end in an ovine iliac venous modelZhongjian Wu, Zhengtong Zhou, Chunjing Bian, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Oncology Reports|December 17, 2008
Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatinYe Bu, Chunhua Lu, Chunjing Bian, et al.
Annals of Surgical Oncology|August 1, 2024
Clinical Effectiveness and Safety of Transarterial Chemoembolization: Hepatic Artery Infusion Chemotherapy Plus Tyrosine Kinase Inhibitors With or Without Programmed Cell Death Protein-1 Inhibitors for Unresectable Hepatocellular Carcinoma-A Retrospective StudyYue Chen, Luyao Jia, Yu Li, et al.
Cryobiology|November 22, 2022
Feasibility and safety of trans-biliary cryoablation: Preclinical evaluation of a novel flexible cryoprobeChao Zhang, Linzhong Zhu, Shousheng Tang, et al.
The British Journal of Radiology|May 5, 2026
Efficacy and safety of transarterial chemoembolization and radiofrequency ablation plus tyrosine kinase inhibitors with or without PD-1 inhibitors for unresectable hepatocellular carcinomaYue Chen, Luyao Jia, Yibo Sun, et al.
Asian Journal of Surgery|June 12, 2022
Identification of key microRNAs in exosomes derived from patients with the severe acute pancreatitisYuanxu Qu, Yixuan Ding, Jiongdi Lu, et al.
Stem Cells and Development|January 18, 2011
NANOG has a role in mesenchymal stem cells' immunomodulatory effectZhao Sun, Qin Han, Yashu Zhu, et al.
Nature Communications|February 12, 2019
NADP<sup>+</sup> is an endogenous PARP inhibitor in DNA damage response and tumor suppressionChunjing Bian, Chao Zhang, Tao Luo, et al.
Journal of Advanced Research|November 7, 2025
The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinomaWentong Mei, Yixuan Ding, Chunjing Bian, et al.
Scientific Reports|April 1, 2024
In vivo evaluation of safety and performance of a tapered nitinol venous stent with inclined proximal end in an ovine iliac venous modelZhongjian Wu, Zhengtong Zhou, Chunjing Bian, et al.
Pageof 4